Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Queralt Jové"'
Autor:
Edson Alves de Lima Junior, Alexandre Abilio de Souza Teixeira, Loreana Sanches Silveira, Queralt Jové, Natalia Álvarez Ladrón, Marcelo G. Pereira, Francisco Javier López-Soriano, Josep M. Argilés, Patrícia Chakur Brum, Silvia Busquets, José Cesar Rosa Neto
Publikováno v:
Frontiers in Oncology, Vol 13 (2024)
BackgroundEven though doxorubicin (DOX) chemotherapy promotes intense muscle wasting, this drug is still widely used in clinical practice due to its remarkable efficiency in managing cancer. On the other hand, intense muscle loss during the oncologic
Externí odkaz:
https://doaj.org/article/e6d66de7ab354f1f95e47620a7b67b2e
Autor:
Jochen Springer, Queralt Jové, Edson Alves deLima Junior, Natalia Álvarez Ladrón, Francisco Javier López‐Soriano, Silvia Busquets, Josep M. Argiles, Daniel L. Marks
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 14, Iss 3, Pp 1244-1248 (2023)
Abstract Background It is known that S‐pindolol attenuates muscle loss in animal models of cancer cachexia and sarcopenia. In cancer cachexia, it also significantly reduced mortality and improved cardiac function, which is strongly compromised in c
Externí odkaz:
https://doaj.org/article/a8b91ebe31ec484db8de8f8dd826cabe
Autor:
Luping Yuan, Jochen Springer, Sandra Palus, Silvia Busquets, Queralt Jové, Edson Alves de Lima Junior, Markus S. Anker, Stephan vonHaehling, Natalia Álvarez Ladrón, Oliver Millman, Annemijn Oosterlee, Agata Szymczyk, Francisco Javier López‐Soriano, Stefan D. Anker, Andrew J.S. Coats, Josep M. Argiles
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 14, Iss 1, Pp 653-660 (2023)
Abstract Background Beta‐blockers and selected stereoisomers of beta‐blockers, like bisoprolol and S‐pindolol (ACM‐001), have been shown to be effective in preclinical cancer cachexia models. Here, we tested the efficacy of stereoisomers of o
Externí odkaz:
https://doaj.org/article/748d4538c7ce45089201c07ab020fbb6
Autor:
Luping Yuan, Jochen Springer, Sandra Palus, Silvia Busquets, Queralt Jové, Edson Alves de Lima Junior, Markus S. Anker, Stephan von Haehling, Natalia Álvarez Ladrón, Oliver Millman, Annemijn Oosterlee, Agata Szymczyk, Francisco Javier López‐Soriano, Stefan D. Anker, Andrew J.S. Coats, Josep M. Argiles
Publikováno v:
Journal of cachexia, sarcopenia and muscleReferences.
Beta-blockers and selected stereoisomers of beta-blockers, like bisoprolol and S-pindolol (ACM-001), have been shown to be effective in preclinical cancer cachexia models. Here, we tested the efficacy of stereoisomers of oxprenolol in two preclinical